2m 2m 2m 2m 2m 2m 2m
ARRIVENT BIO (AVBP)
NASDAQ
$20.33+$1.20 (+6.30%)
Price as of Oct 22, 2026 7:30 PM EDT- $942.8MMarket Cap
- 3.41%1-Year Change
- BiotechnologyIndustry
ARRIVENT BIO (AVBP)
$20.33+$1.20 (+6.30%)
AVBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.12 | ||
Change | +$0.27 (+1.43%) | ||
Open | $19.07 | ||
High | $19.44 | ||
Low | $18.68 | ||
Previous Close | $18.85 | ||
Volume | 1,489,214 | ||
30-Day Average Volume | 2,010,748 | ||
1-Week Change | 18.02% | ||
1-Month Change | -35.71% | ||
1-Year Change | 3.41% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 49.3M | ||
Total Assets | $394.7M | ||
Market Cap | $942.8M | ||
Enterprise Value | $788.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$49.9M | ||
Free Cash Flow | -$39.6M | ||
EBIT | -$49.9M | ||
EBITDA | -$50.4M | ||
Net Working Capital | $366.3M | ||
EPS | -$1.05 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -18 | ||
PEG | 2 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue